Supriya Lifescience to host analyst meet on June 18
Supriya Lifescience Limited has scheduled a virtual group meeting with analysts and institutional investors for June 18, 2026, between 02:00 PM and 03:00 PM IST. The meeting is conducted under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and the Investor Presentation has been uploaded to the company website and stock exchanges.

*this image is generated using AI for illustrative purposes only.
Supriya Lifescience Limited will host a virtual group meeting with analysts and institutional investors on June 18, 2026. The interaction is scheduled between 02:00 PM and 03:00 PM IST, providing a platform for the company's officials to engage with Kotak PCG clients.
The meeting follows the relevant provisions of the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015. As part of the disclosure process, the company has made the Investor Presentation available to the public. The document has been uploaded on the website of supriya lifescience and submitted to the stock exchanges.
Meeting Details
The schedule for the interaction is outlined below:
| Sr. No. | Meeting with | Date & Time | Format | Mode |
|---|---|---|---|---|
| 1. | Group Meeting with Kotak PCG Clients | Thursday, June 18, 2026 02:00 PM – 03:00 PM |
Group Meeting | Virtual |
The company noted that the scheduled date is subject to change due to exigencies on the part of the company or the analysts and investors involved. This information was submitted to the exchanges pursuant to Regulation 30(6) of the SEBI Listing Regulations.
Historical Stock Returns for Supriya Lifescience
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -3.44% | -5.04% | +32.79% | +25.41% | +32.17% | +133.94% |
What key strategic updates or growth drivers is Supriya Lifescience expected to highlight during the meeting?
How might the outcomes of this meeting influence investor sentiment and stock performance in the short term?
Will the company provide guidance on future earnings or upcoming product launches in the investor presentation?


































